ReviewGesundheitswesen (Bundesverband der Arzte des Offentlichen Gesundheitsdienstes (Germany))2020
[Quarantine Alone or in Combination with Other Public Health Measures to Control COVID-19: A Rapid Review (Review)].
Review in Gesundheitswesen (Bundesverband der Arzte des Offentlichen Gesundheitsdienstes (Germany)), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Global Trends and Research Hotspots of Exercise for Intervening Diabetes: A Bibliometric Analysis.Frontiers in public health · 2022Pooled it
- Effective public health measures to mitigate the spread of COVID-19: a systematic review.BMC public health · 2021Pooled it
- Laboratory readiness and genomic surveillance of Covid-19 in the capital of Brazil.PLOS global public health · 2025Article
- The impact of COVID-19 on quality of life among Lebanese adults: a cross-sectional study.Frontiers in public health · 2025Article
- Adherence to social distancing measures in southern Brazil, 2020/2021: a cross-sectional study.Einstein (Sao Paulo, Brazil) · 2024Article
- Development and validation of the Environmental Confinement Stressors Scale (ECSS-20).Frontiers in psychology · 2024Article
- Association between attitudes toward the COVID-19 vaccines and mental health among 140,259 college students in China.Zeitschrift fur Gesundheitswissenschaften = Journal of public health · 2023Article
- Anxiety, insomnia, and depression during COVID-19 lockdown in elite individual and team sport athletes.Psicologia, reflexao e critica : revista semestral do Departamento de Psicologia da UFRGS · 2022Article
- Evaluation of Non-Pharmacological Measures Implemented in the Management of the COVID-19 Pandemic in Romania.Healthcare (Basel, Switzerland) · 2022Article
- Mitigating virus spread through dynamic control of community-based social interactions for infection rate and cost.Social network analysis and mining · 2022Article
- Domestic Violence Before and During the COVID-19 Pandemic–A Comparison of Two Representative Population Surveys.Deutsches Arzteblatt international · 2021Article
- Attitudes and predictive factors of psychological distress and occupational burnout among dentists during COVID-19 pandemic in Turkey.Current psychology (New Brunswick, N.J.) · 2021Article
- The Impact of Control Measures and Holiday Seasons on Incidence and Mortality Rate of COVID-19 in Iran.Journal of research in health sciences · 2020Observational
- Effects of Comorbid Factors on Prognosis of Three Different Geriatric Groups with COVID-19 Diagnosis.SN comprehensive clinical medicine · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCOVID-19 (coronavirus disease 2019) is a new, rapidly emerging zoonotic infectious disease, that was reported to the World Health Organization for the first time on 31 December 2019. Currently, no effective pharmacological interventions or vaccines are available to treat or prevent COVID-19, therefore nonpharmacological public health measures are more in focus.
objectivesThe aim was to assess the effects of quarantine - alone or in combination with other measures - during coronavirus outbreaks.
methodsBecause of the current COVID-19 pandemic, WHO commissioned a rapid review. To save time, the method of systematic reviews was slightly and with caution modified. This publication is a summary of the most important aspects of the rapid review, translated into German by members of the WHO Collaborating Centre at the Danube University Krems (Austria).
resultsOverall, 29 studies were included. Ten modeling studies focused on COVID-19, 4 observational studies and 15 modeling studies focused on SARS and MERS. The modeling studies consistently reported a benefit of the simulated quarantine measures. For example, the models estimated that quarantine of people exposed to confirmed or suspected cases of COVID-19 prevented between 44 and 81% of the cases that would otherwise have happened and 31 to 63% of the deaths, when compared to no such measures. In regard to costs, the earlier the quarantine measures are implemented, the greater the cost savings will be.
conclusionOur confidence in the evidence is very limited. This is mainly because the COVID-19 studies based their models on the limited data that have been available in the early weeks of the pandemic and made different assumptions about the virus. The studies of SARS and MERS are not completely generalizable to COVID-19. Despite only having limited evidence, all the studies found quarantine to be important for controlling the spread of severe coronavirus diseases. Looking to the coming months, in order to maintain the best possible balance of measures, decision makers must continue to constantly monitor the outbreak situation and the impact of the measures they implement.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.